<DOC>
	<DOCNO>NCT00487981</DOCNO>
	<brief_summary>The purpose study evaluate Spinal Cord Stimulation ( SCS ) therapy individual suffer painful diabetic peripheral neuropathy . Patients invited participate study eligible SCS therapy , already select therapy Advanced Bionics Precision system independent possible inclusion study . The device , accessory , procedure associate device placement indication use consistent current approve product labeling .</brief_summary>
	<brief_title>Spinal Cord Stimulation Painful Diabetic Neuropathy</brief_title>
	<detailed_description>The management neuropathic pain often difficult , available treatment option rarely provide complete relief . Although prevention mean glycemic control first priority , 20 % patient develop Diabetic Peripheral Neuropathy ( DPN ) require active drug therapy . Select anti-depressants , anti-epileptics , opioids generally first-line pharmacologic treatment neuropathic pain . Topical cream use achieve local control . Nonconventional therapy include acupuncture magnet therapy . However , treatment limit utility marginal efficacy . Various form electric stimulation show improve symptom DPN . Advances spinal cord stimulation technology encourage broad use treatment modality management chronic painful DPN .</detailed_description>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Have chronic neuropathic pain least one limb score least 3 use Michigan Neuropathy Screening Instrument ( MNSI ) secondary Type 1 Type 2 diabetes Have chronic neuropathic pain least 12 month Be 18 year age old Be refractory pain medication include gabapentin use pain medication contraindicate tolerated side effect medical condition Be appropriate candidate SCS therapy already decide use Precision system Be willing able comply study related procedure visit Be capable read understanding patient information material give write informed consent Are smoker Have chronic pain condition likely confound evaluation study endpoint Have significant medical condition likely interfere study procedure likely confound evaluation study endpoints peripheral vascular disease neurological disorder unrelated diabetic neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Pain</keyword>
	<keyword>Implantable stimulation device</keyword>
	<keyword>Neuropathy</keyword>
</DOC>